Stepwise therapy questions ask for the next best addition for a patient who is not controlled.
Asthma
Intermittent: as-needed short-acting beta agonist or low-dose inhaled steroid with formoterol. Persistent: low-dose inhaled corticosteroid, then add a long-acting beta agonist, increase the dose and consider biologics for severe allergic or eosinophilic disease. Peak flow monitors action plans. Treat triggers and comorbid rhinitis.
COPD
Stop smoking (the only intervention that slows decline). Long-acting bronchodilators (LAMA, LABA) are first line, with an inhaled steroid added for frequent exacerbations and high eosinophils. Pulmonary rehabilitation, influenza, pneumococcal, RSV and COVID vaccines. Long-term oxygen for PaO2 of 55 mmHg or less (or saturation of 88 percent or less).
Exacerbations
Short-acting bronchodilators, 5 days of oral prednisone and antibiotics for increased sputum purulence. Noninvasive ventilation for hypercapnic respiratory failure.
Keep going in step 2 ck clinical management
- Pneumonia severity: CURB-65 and deciding where to treat
- Cirrhosis and hepatitis inpatient management on Step 2 CK
- Endocrine work-up on Step 2 CK: thyroid nodules, adrenal masses and hypercalcemia
- Hematology workup: anemia, polycythemia and thrombocytopenia